CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Planned sale Chief Financial Officer sold 29,700 shares at an average $60.16 ($1,786,636)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $55.95 ($559,549)
- 4 Gift Chief Executive Officer gave 30,000 shares (gift)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Executive Officer sold 50,895 shares at $67.91 ($3,456,279)
- 4 Open-market sale Chief Executive Officer sold 4,242 shares at $66.60 ($282,517)
- 4 Open-market sale General Counsel and Secretary sold 1,076 shares at $66.60 ($71,662)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Chief Executive Officer gave 6,000 shares (gift)
- 4 Open-market sale Chief Executive Officer sold 13,081 shares at $58.15 ($760,660)
Page 5 of 45 · 883 filings